Chemoinformaics analysis of Malvidin 3,5-diglucoside
Molecular Weight | 691.035 | nRot | 9 |
Heavy Atom Molecular Weight | 655.755 | nRig | 29 |
Exact Molecular Weight | 690.156 | nRing | 5 |
Solubility: LogS | -2.301 | nHRing | 3 |
Solubility: LogP | -0.329 | No. of Aliphatic Rings | 2 |
Acid Count | 1 | No. of Aromatic Rings | 3 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 2 |
nHetero | 18 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
nHA | 16 | APOL | 87.5818 |
nHD | 10 | BPOL | 47.2642 |
QED | 0.114 |
Synth | 4.963 |
Natural Product Likeliness | 1.443 |
NR-PPAR-gamma | 0.152 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.004 |
Pgp-sub | 0.995 |
HIA | 0.901 |
CACO-2 | -6.624 |
MDCK | 0.0000507 |
BBB | 0.167 |
PPB | 0.689765 |
VDSS | 0.566 |
FU | 0.300745 |
CYP1A2-inh | 0.045 |
CYP1A2-sub | 0.072 |
CYP2c19-inh | 0.005 |
CYP2c19-sub | 0.105 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.077 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.178 |
CYP3a4-inh | 0.002 |
CYP3a4-sub | 0.004 |
CL | 1.647 |
T12 | 0.842 |
hERG | 0.403 |
Ames | 0.251 |
ROA | 0.004 |
SkinSen | 0.125 |
Carcinogencity | 0.023 |
EI | 0.013 |
Respiratory | 0.014 |
NR-Aromatase | 0.712 |
Antiviral | Yes |
Prediction | 0.607976 |